Drug Approval | December 09, 2021
Alembic receives tentative USFDA approval for Selexipag tablets
The tablets are indicated for the treatment of pulmonary arterial hypertension
The tablets are indicated for the treatment of pulmonary arterial hypertension
Dr. Reddy's valsartan tablets, USP are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and 320 mg tablets in bottle count sizes of 90
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)
The company is moving towards complex and more differentiated products
Nelarabine is in a class of medications called antimetabolites
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The drug helps in managing cholesterol
The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
